190 related articles for article (PubMed ID: 15660830)
1. Prolonged platelet preservation by transient metabolic suppression.
Badlou BA; Ijseldijk MJ; Smid WM; Akkerman JW
Transfusion; 2005 Feb; 45(2):214-22. PubMed ID: 15660830
[TBL] [Abstract][Full Text] [Related]
2. Metabolic energy reduction by glucose deprivation and low gas exchange preserves platelet function after 48 h storage at 4 degrees C.
Badlou BA; van der Meer PF; Akkerman JW; Smid WM; Pietersz RN
Vox Sang; 2007 May; 92(4):311-8. PubMed ID: 17456155
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
4. Platelet ADP response deteriorates in synthetic storage media.
Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
[TBL] [Abstract][Full Text] [Related]
5. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
[TBL] [Abstract][Full Text] [Related]
7. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days.
Valeri CR; Ragno G; Marks PW; Kuter DJ; Rosenberg RD; Stossel TP
Transfusion; 2004 Jun; 44(6):865-70. PubMed ID: 15157253
[TBL] [Abstract][Full Text] [Related]
8. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
Picker SM; Schneider V; Gathof BS
Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
[TBL] [Abstract][Full Text] [Related]
9. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation.
Javela K; Eronen J; Sarna S; Kekomäki R
Transfusion; 2005 Sep; 45(9):1504-11. PubMed ID: 16131384
[TBL] [Abstract][Full Text] [Related]
10. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
12. In vitro testing of fresh and lyophilized reconstituted human and baboon platelets.
Valeri CR; Macgregor H; Barnard MR; Summaria L; Michelson AD; Ragno G
Transfusion; 2004 Oct; 44(10):1505-12. PubMed ID: 15383025
[TBL] [Abstract][Full Text] [Related]
13. Platelet function under high-shear conditions from platelet concentrates.
Jilma-Stohlawetz P; Horvath M; Eichelberger B; Koren D; Jilma B; Panzer S
Transfusion; 2008 Jan; 48(1):129-35. PubMed ID: 17894788
[TBL] [Abstract][Full Text] [Related]
14. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
15. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
Valeri CR; Macgregor H; Ragno G
Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
[TBL] [Abstract][Full Text] [Related]
16. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days.
Tynngård N; Studer M; Lindahl TL; Trinks M; Berlin G
Transfusion; 2008 Aug; 48(8):1669-75. PubMed ID: 18482187
[TBL] [Abstract][Full Text] [Related]
17. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
18. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
19. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
Sandgren P; Shanwell A; Gulliksson H
Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions.
Vetlesen A; Mirlashari MR; Torsheim IA; Kjeldsen-Kragh J
Transfusion; 2005 Aug; 45(8):1349-55. PubMed ID: 16078925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
